Janusz, CB; Jauregui, B; Sinha, A; Clark, AD; Bolaños, BM; Resch, S; Toscano, C; Andrus, JK; (2012) Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean. Value in health regional issues, 1 (2). pp. 248-253. ISSN 2212-1099 DOI: https://doi.org/10.1016/j.vhri.2012.10.003 Full text not available from this repository.

Woods, B; Hawkins, N; Dunlop, W; O'Toole, A; Bramham-Jones, S; (2012) Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: A cost-utility analysis. Value in health, 15 (5). pp. 759-70. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2012.03.1389 Full text not available from this repository.

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R; (2004) Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation. Health technology assessment (Winchester, England), 8 (38). iii-iv, 1-196. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2545583

Bramley, D; Graves, N; Walker, D; (2003) The cost effectiveness of universal antenatal screening for HIV in New Zealand. AIDS (London, England), 17 (5). pp. 741-748. ISSN 0269-9370 DOI: https://doi.org/10.1097/01.aids.0000050810.06065.36 Full text not available from this repository.